RG-6315

N/A

Report date: 2023/03/05 16:38:11

Base Information

Drug NameRG-6315
Drug Alias NameRG-6315
ClassificationBiologics
Mechanisms of ActionTransforming growth factor beta receptor 2 inhibitorsTransforming growth factor beta 3 inhibitors
TargetsTransforming growth factor beta receptor 2Transforming growth factor beta 3
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsScleroderma, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A